Elixinol Wellness Corrects Director Interest Notice and Tightens Disclosure Controls

Elixinol Wellness ( (AU:EXL) ) has issued an update.

Elixinol Wellness has corrected a previously lodged director’s interest notice after discovering that listed options held by chair Gavin Evans were omitted due to an administrative oversight. The company has filed an updated notice reflecting Evans’ 7,804,417 listed options and says it has strengthened internal processes to ensure future compliance with ASX disclosure obligations.

The amendment, which does not involve any change in consideration or disposal of securities, clarifies the full extent of Evans’ indirect holdings via his super fund. The move is aimed at reinforcing transparency for investors and aligning the company’s reporting with corporate governance standards required of ASX-listed entities.

The most recent analyst rating on (AU:EXL) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Elixinol Wellness stock, see the AU:EXL Stock Forecast page.

More about Elixinol Wellness

Elixinol Wellness Ltd is a global health and wellness company focused on hemp and other plant-derived food, skincare, and nutraceutical products. Operating in Australia and the U.S., it runs a vertically integrated business across human nutrition, human wellness, pet wellness, and superfood ingredients, selling through grocery, wholesale, and e-commerce under brands such as Hemp Foods Australia, The Healthy Chef, Mt Elephant, Soul Seed, Field Day, and The Australian Superfood Co.

Average Trading Volume: 892,533

Technical Sentiment Signal: Sell

Current Market Cap: A$3.73M

See more data about EXL stock on TipRanks’ Stock Analysis page.